Evidera
Curran Nelson is an experienced project manager with a strong background in clinical development and personalized medicine. Currently serving as Project Manager for Peri and Post Approval Operations at Evidera since November 2021, Curran previously held the role of Associate Project Manager at Synteract, contributing to Phase I – IV clinical development programs. Prior experience includes several positions at Cancer Genetics, Inc., including Project Manager, Associate Project Manager, and Sales Support Specialist, where Curran focused on cancer diagnostics and treatments. Curran began the professional journey at Fleet Feet Sports - Carrboro as a Sales Associate and holds a Bachelor's degree in Kinesiology and Exercise Science from the University of North Carolina at Chapel Hill.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.